You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
23 August 2019 - Genmab A/S (CPH: GMAB), a biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer, announced on Thursday the approval by the Ministry of Health, Labour an...
23 August 2019 - Science-led biopharmaceutical company AstraZeneca Plc (LON:AZN) announced on Thursday that it has agreed to buy a US Food and Drug Administration (FDA) Priority Review Voucher (PRV) for a total cash consideration of USD95m from a sub...
23 August 2019 - Science-led biopharmaceutical company AstraZeneca Plc (LON:AZN) announced on Thursday the receipt by its partner FibroGen (China) Medical Technology Development Co Ltd (FibroGen China) of marketing authorisation for roxadustat in Chi...
23 August 2019 - Healthcare company CrossBay Medical Inc reported on Thursday the receipt of marketing clearance to commercialise its Endometrial Tissue Sampler (ETS) using CrossGlide technology for use in endometrial biopsy procedures in Europe.Cros...
23 August 2019 - Healthcare company Drawbridge Health reported on Thursday the receipt of US Food and Drug Administration (FDA) 510(k) clearance for its OneDraw A1C Test System for monitoring the long-term control of blood sugar (glucose) in people w...
22 August 2019 - - US-based VenatoRx Pharmaceuticals has added pharmaceutical industry veterans, Jennifer Ellis, Dr. Paul McGovern and Lauren P. Tornetta to its development team, the company said.
These appointments come as the company c...
These appointments come as the company c...
22 August 2019 - - Israel-based clinical-stage biopharmaceutical company ChemomAb Ltd has released results from its Phase 1 single administration study evaluating the subcutaneous formulation of CM-101 in healthy volunteers, the company said.
<...
<...